Summary
Updated Aug 30, 2026
Yuan Xu files SEC Form 4 reports at FATE THERAPEUTICS INC (FATE). 3 SEC Form 4 filings on record going back to 2025, most recently on 15 June 2026.
Recent Transactions
1Every recent SEC Form 4 transaction Yuan Xu has reported, most recent first.
Other Insiders Active in the Same Stocks
Insiders who reported open-market trades in the last 12 months at the companies Yuan Xu files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- GILEAD SCIENCES, INC. - $2.00M of XLO open-market activity in the last 12 months
- Bahram Valamehr - $168K of FATE open-market activity in the last 12 months
- Cindy Tahl - $155K of FATE open-market activity in the last 12 months
- James Samuel Shannon - $44K of XLO open-market activity in the last 12 months
- Christopher James Frankenfield - $5K of XLO open-market activity in the last 12 months
- Kevin M. Brennan - $1K of XLO open-market activity in the last 12 months
More Notable Insiders
Other corporate insiders with significant SEC Form 4 track records on InsiderAlpha:
Frequently Asked Questions
Who is Yuan Xu?
Yuan Xu is a corporate insider of FATE THERAPEUTICS INC (FATE). InsiderAlpha holds 3 primary Form 4 filings for them, the earliest from 2025, updated as new SEC EDGAR filings are processed.
How many SEC Form 4 filings has Yuan Xu submitted recently?
2 primary Form 4 filings in the last 90 days, covering 2 companies.
Where can I see all of Yuan Xu's SEC filings?
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Learn More
Follow Yuan Xu and every insider like them
A free account opens the full scored daily plan and every past day, a watchlist for any ticker, and 3 months of price history on every company page. No card.
Free plan available · Paid plans start with a 7-day free trial
